US FDA Approves First Ever Biosimilar – Zarxio
The US FDA has approved the first ever Biosimilar – Novartis/Sandoz’s Zarxio. Biosimilars are about a third cheaper than brand-name biologic drugs, on average, in countries where they are in use, according to Express Scripts, the nation’s largest manager of… Continue Reading